— Know what they know.
Not Investment Advice
Also trades as: RENE.L (LSE) · $vol 0M

RNUGF OTC

ReNeuron Group plc
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -99.5% 5Y: -99.9%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 49 · $62891 mcap · 46M float · 0.0009% daily turnover

Balance Sheet Trends

Total Assets
$10M -44.3% ▼
5Y CAGR: -25.7%
Total Liabilities
$5M -38.3% ▼
5Y CAGR: -5.1%
Shareholders Equity
$5M -48.9% ▼
5Y CAGR: -32.7%
Cash & Investments
$7M -50.8% ▼
5Y CAGR: -28.2%
Total Debt
$421K -25.1% ▼
5Y CAGR: -15.9%
Net Debt
-$6M +36.2% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022FY2023
— Assets —
Cash$20M$13M$15M$10M$6M
Short-Term Investments$6M$0$8M$5M$1M
Cash & ST Investments$26M$13M$22M$15M$7M
Net Receivables$0$696K$444K$536K$500K
Inventory-$4M-$7M$0-$2M-$2M
Other Current Assets$3M$12M$2M$3M$3M
Total Current Assets$30M$19M$24M$16M$9M
Property, Plant & Equip.$632K$1M$686K$661K$621K
Goodwill & Intangibles$186K$186K$186K$186K$186K
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$818K$1M$872K$847K$807K
Total Assets$31M$20M$25M$17M$10M
— Liabilities —
Accounts Payable$3M$2M$788K$734K$319K
Short-Term Debt$0$0$0$0$0
Deferred Revenue-$5M-$4M$0-$6M$0
Other Current Liabilities$131K$4M$76K$6M$4M
Total Current Liabilities$7M$6M$6M$7M$4M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$864K$707K$562K$416K$268K
Total Liabilities$7M$7M$6M$7M$5M
— Equity —
Common Stock$316K$318K$569K$571K$572K
Retained Earnings-$117M-$128M-$138M-$147M-$152M
Accumulated OCI$43M$0$0$40M$40M
Total Stockholders Equity$23M$13M$19M$10M$5M
Total Liabilities & Equity$31M$20M$25M$17M$10M
— Key Metrics —
Total Debt$1M$873K$719K$562K$421K
Net Debt-$19M-$12M-$14M-$9M-$6M
Total Investments$6M$0$8M$5M$1M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms